The _________________ is a common metric for characterizing risk of non-cancer risk, while ______________________ is acommon meteric for characterizing cancer risk.

Question

BlackTom AI · Accepted Answer

This item asks us to fill in two blanks about risk assessment metrics. Rather than listing options, it changes the task to evaluating the standard metrics used in risk characterization.
A common metric for non-cancer risk is the hazard quotient, which compares the estimated exposure to a reference dose to assess whether the exposure might be unsafe for non-cancer effects. If the exposure level is below the reference dose, the hazard quotient is typically less than 1, suggesting acceptable risk for non-cancer endpoints.
For cancer risk, the standard metric is excess lifetime cancer risk, which estimates the probability of developing cancer over a lifetime due to exposure. This measure focuses on probabilistic cancer outcomes rather than threshold-based non-cancer effects.
In contrast, one could critique other options by noting that some metrics are not designed for cancer risk (for example, using a non-cancer threshold in a cancer context would be inappropriate) or that some measures do not provide probabilistic lifetime risk estimates. Without actual alternative choices provided, we cannot compare each option, but the paired phrasing aligns with established risk assessment practice: hazard quotient for non-cancer risk and excess lifetime cancer risk for cancer risk.
If you were given multiple options, you would evaluate each one to see whether it corresponds to the non-cancer hazard quotient or the cancer-related excess lifetime risk, ensuring that the first blank aligns with non-cancer risk assessment and the second with cancer risk assessment.

EH 206 Self-Assessment 05

The _ is a common metric for characterizing risk of non-cancer risk, while ______ is acommon meteric for characterizing cancer risk.

View Explanation

Log in for full answers

Similar Questions

Assume the excess lifetime cancer risk for a certain level of exposure to the chemical acrylamide is estimated to be 7.2 x 10-3. This risk is ____________________ generally accepted criteria for follow-up investigation or intervention.

Which of the following is/are true about risk assessment?

A chemical that has very potent bioactivity has been deemed not a risk to you. You apply what you learned in ETX10 and conclude this judgement is reasonable because (choose the best answer)

What steps of risk assessment does not consider the level of exposure?

___________ refers to using statistical methods to estimate the degree of harm likely to be caused by a toxic compound or behavior.

What is the overall objective of a risk assessment?

More Practical Tools for Students Powered by AI Study Helper

Homework AI Solver

Stylized AI Paper Writer

Plagiarism Checker Assistant

Citation AI Academic Writing Tool

In-Class Translation Assistant

AI Note Generator

AI Quiz Answers

Past Exam Questions from University Test Bank

Smart Practice Assistant

Adaptive Practice

Making Your Study Simpler